Eli Lilly Corp. buy Scotiabank
Start price
05.02.26
/
50%
€875.30
Target price
05.02.27
-
Performance (%)
17.13%
Price
07.08.26
€1,025.2
Summary
This prediction is currently active. The prediction currently has a performance of 17.13%. This prediction currently runs until 05.02.27. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 2.932% | 2.932% |
| iShares Core DAX® | 2.573% | 3.502% |
| iShares Nasdaq 100 | 4.858% | 0.654% |
| iShares Nikkei 225® | 5.590% | -0.246% |
| iShares S&P 500 | 3.250% | 2.083% |
Comments by Scotiabank for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Ratings data for LLY provided by MarketBeat

